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Abstract: 
Patients with sickle cell anemia (SCA) have usually lower diastolic, systolic and mean blood 
pressure (BP) than the general population. However, BP values ≥ 120/70 mmHg considerably 
increase the risk for acute and chronic complications in SCA. The aim of this study was to 
identify biological factors associated with relative hypertension in adults with SCA. We 
compared the hematological, lipid and hemolytic profiles, as well as blood viscosity, between 
SCA patients with normal BP (< 120/70 mmHg, n=54) and those with relative hypertension 
(BP ≥ 120/70 mmHg, n=43). Our results demonstrated that male gender (OR: 3.49; 95%CI 
1.20 to 10.16, p < 0.05), triglycerides (OR: 9.19; 95% CI 2.29 to 36.95, p < 0.01), blood 
viscosity (OR: 1.35; 95% CI 1.01 to 1.81, p < 0.05) and body mass index (OR: 1.37; 95% CI 
1.14 to 1.64, p < 0.01) were independent risks factors for relative hypertension in SCA. No 
association was found between the BP status and the positive history of painful vaso-
occlusive crisis or acute chest syndrome. An association between triglycerides level and the 
occurrence of these two major acute complications was detected. Our study suggests that male 
gender, increased triglycerides level, BMI and blood viscosity could increase the risk for 
developing relative hypertension in SCA. In addition, our results support a role of moderately 
elevated triglycerides in the pathophysiology of vaso-occlusive events. 
  
 
 
Key words: Sickle cell anemia, relative hypertension, blood viscosity, vaso-occlusive crisis, 
atherogenic index of plasma 
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Introduction:  
Patients with sickle cell anemia (SCA) have lower systolic, diastolic and mean blood pressure 
(BP) compared with age- and sex-matched controls [1,2,3,4]. The prevalence of hypertension 
(HTN; BP ≥ 140/90 mmHg) is lower in SCA than in the general population [1,2,4,5]. At that 
time, no specific recommendations have been proposed by the United States Preventive 
Services Task Force (USPSTF) regarding the defining criteria (and management) of HTN in 
SCA. This is a major concern since increased systolic BP (even if lower than 140 mmHg) has 
been associated with higher risk of stroke [4,6,7] and mortality [3] in SCA. However, 
recently, Gordeuk et al [5] showed that relative HTN (rHTN), defined as BP ≥ 120/70 mmHg 
in their study, and that HTN (BP ≥ 140/90), considerably increased the risk for pulmonary 
hypertension and renal dysfunction.  
 
According to the Poiseuille law, blood viscosity is a key component of vascular resistance and 
mean BP. Several studies, in non-SCA population, reported an association between increased 
blood viscosity and HTN [8,9]. Although blood viscosity is usually lower in SCA population 
compared to the general population [10], elevated blood viscosity increases the risk for vaso-
occlusive events in SCA [11,12,13]. But, surprisingly, the association of BP and blood 
viscosity has not been studied so far in SCA and it remains unknown if rHTN, as defined by 
Gordeuk et al [5] or HTN, could be related to alterations in blood viscosity.  
 
Moreover, a recent growing interest has been devoted to the study of lipid levels in SCA 
because they might be involved in the pathophysiology of several complications. The lipid 
profile differs significantly between SCA patients and the general population [14,15,16], with 
SCA patients usually having low levels of total cholesterol and low-density lipoprotein-
cholesterol (LDL-C), which is consistent with the virtual absence of atherosclerosis among 
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SCA patients [16]. But, several studies also reported decreased high-density lipoprotein-
cholesterol (HDL-C) level in SCA patients [16,17], which may lead to an increased risk for 
endothelial dysfunction in this population [16,18]. This association could be related to the 
release of oxidized fatty acids during lipolysis, leading to endothelial cell inflammation [19]. 
Moreover, the atherogenic index of plasma (AIP = log (TG/HDL-C), with TG corresponding 
to triglycerides level) is increased in SCA and is also a factor of endothelial dysfunction [16]. 
However, it remains undefined whether this specific lipid profile could favor the development 
of rHTN or HTN in SCA. 
 
The aim of the present study was to identify biological factors associated with systemic rHTN 
or HTN (as defined in a previous study [5]) in SCA adult patients to gain insight into the 
pathophysiology of HTN in this disease. We hypothesized that blood viscosity and lipids 
profiles are associated with systemic rHTN in adults with SCA.  
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Material and methods 
Patients 
The study took place between May 2010 and December 2011, and included 97 adults with 
SCA (M/F = 43/54) regularly followed by the Sickle Cell Center at the Academic Hospital of 
Pointe-à-Pitre (Guadeloupe, French West Indies). All patients were in steady-state condition 
at the time of the study: no blood transfusions in the previous three months and absence of 
acute episodes (infection, vaso-occlusive crisis (VOC), acute chest syndrome (ACS), stroke, 
priapism) at least two months before inclusion into the study. SCA patients under treatment 
modifying blood rheology were also excluded, except for those on hydroxyurea (HU). 
All patients were informed about the purpose and procedures of the study, and gave their 
written consent. The study was conducted in accordance with the guidelines set by the 
Declaration of Helsinki and was approved by the Regional Ethics Committee (CPP Sud/Ouest 
Outre Mer III, Bordeaux, France, registration number: 2010-A00244-35).  
 
Clinical parameters:  
Height (cm) and weight (kg) were measured for all patients. Body mass index was calculated 
(BMI = weight/height2 (Kg/m2). Systolic and diastolic BPs were measured as recommended 
[20]. BP values < 120/70 mmHg were considered as normal (NORM group; n = 54). Patients 
with BP values ≥ 120/70 mmHg and < 140/90 mmHg were considered as having rHTN (n = 
38), and those with BP levels ≥ 140/90 mmHg had HTN (n = 5) [5]. Because of the limited 
number of patients in the latter group, the two groups with either rHTN or HTN were pooled 
to create a single group (HTN group; n = 38 + 5 = 43). Pulse pressure (PP) was calculated for 
the two groups as the difference between systolic and diastolic BP. Heart rate (HR) and 
oxygen saturation (SpO2) were measured for each patient. Charts were retrospectively 
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reviewed by two physicians to record all ACS and VOC episodes, as defined in a previous 
study [11], within the previous year of blood sampling.  
 
Genetic parameters: 
SCA diagnosis was made by isoelectrofocusing (Multiphor II™ System, GE HEALTH 
CARE, Buck, UK), citrate agar electrophoresis, and cation-exchange high performance liquid 
chromatography (VARIANT™, Bio-Rad Laboratories, Hercules, CA, USA), and was 
confirmed by DNA studies [21]. Polymerase Chain Reaction (Gap-PCR) was used to detect 6 
common alpha-thalassemia deletions [22,23].  
 
Biological parameters:  
Blood samples were drawn after a 12-hrs overnight fasting, between 8:00 a.m. and 10:00 a.m., 
and were immediately used for analyses. Measurements of serum lipids levels (total 
cholesterol, LDL-C, HDL-C and triglycerides (TG)) and hemolytic markers (bilirubine, BIL; 
lactate dehydrogenase, LDH; aspartate aminotransferase, AST) were performed using 
standard biochemistry, and AIP was calculated. TG level below 1.69 mM is currently 
considered as normal. A value of AIP greater than 0.21 suggests increased cardiovascular risk 
[24,25,26]. A principal component analysis was used to derive a hemolytic component from 
the 4 hemolytic markers measured (i.e. BIL, LDH, AST and reticulocytes expressed in 
percentage). This standard statistical data reduction approach uses conventional clinical 
measurements to explain the maximum-shared variance among these indirect measures of 
hemolysis [27]. The hemolytic component has recently been demonstrated to reflect 
intravascular hemolysis assessed by measurements of the cell-free plasma hemoglobin [27]. 
Hemoglobin concentration (Hb), hematocrit (Hct), mean corpuscular volume (MCV), mean 
corpuscular hemoglobin (MCH), reticulocytes (RET), red blood cell (RBC), platelet (PLT) 
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and white blood cell (WBC) counts were determined using hematology analyzer (Max M-
Retic, Coulter, USA).  
Blood viscosity was measured after complete oxygenation of the blood, at native Hct, at 25°C 
and at a shear rate of 225 s−1 using a cone/plate viscometer (Brookfield DVII+ with CPE40 
spindle, Brookfield Engineering Labs, Natick, MA) [28].  
 
Statistical analysis 
Results are presented as means ± SD. Unpaired Student’s t-test and chi-square test were used 
for continuous covariates and for categorical covariates, respectively, to compare biological 
parameters between the different groups. Pearson test was used for correlations. Principal 
component analysis was used to derive the hemolytic component. 
To identify risk factors associated with HTN in SCA patients, we used a binary (i.e., presence 
or absence of HTN) multivariate logistic model. Variables of interest at p < 0.10 by univariate 
analysis were included as covariates in the multivariate regression models. Significance level 
was defined as p < 0.05. Analyses were conducted using SPSS (v. 20, IBM SPSS Statistics, 
Chicago, IL).  
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Results 
 
General characteristics in NORM and HTN groups 
Table 1 shows the general characteristics of the two groups where no difference was observed 
for age, SpO2, HR, percentages of HbS and HbF, and frequency of patients receiving 
hydroxyurea treatment. In addition, the proportion of patients with a positive history of VOC 
or ACS was not different between the two groups. HTN group had higher PP, weight and 
BMI, compared to the NORM group (p < 0.01). Although the difference did not reach 
statistical significance, the gender distribution tended to differ between the two groups (p < 
0.10). 
 
Hematological parameters and hemolytic profile in NORM and HTN groups 
Table 2 shows the results of the hematological and hemolytic parameters. The two groups 
were not different regarding alpha-thalassemia frequency, WBC and PLT counts, MCV and 
MCHC. In contrast, RBC count, Hct and Hb levels were greater in the HTN group in 
comparison with the NORM group (p < 0.01). Except for a trend toward lower bilirubin 
concentration in the HTN group compared to the NORM group (p < 0.1), the other markers 
were not different between the two groups. However, the hemolytic component derived from 
the 4 hemolytic markers was lower in the HTN group than in the NORM group (p < 0.05). 
The hemolytic component had a mean of 0 (SD = 1.0) and predicted 49.2% of the variation 
among all four variables (Eigenvalue = 1.97). 
 
Lipids profile and blood viscosity in NORM and HTN groups 
Total cholesterol, HDL-C and LDL-C did not differ between the two groups (Table 3). In 
contrast, TG levels (p < 0.01) and blood viscosity (p < 0.05) were greater in the HTN group 
than in the NORM group. AIP was not significantly different between the two groups (p < 
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0.1) but a significant greater proportion of patients with AIP > 0.21, which may suggest 
higher cardiovascular risk [24,25,26], was detected in the HTN group (14.6%) than in the 
NORM group (7.3%; p < 0.05). AIP correlated with HbF (r = -0.26; p < 0.05) and PP (r = 
0.25; p < 0.05).  
 
At that time, no large study has identified lipids cut-off values above which SCA patients 
might be at risk for cardiovascular events. The American Heart Association defined cut-off 
values in the general population with TG level below 1.69 mM being normal. Accordingly to 
this classification, eighty-five patients had normal TG level, eleven patients had TG level 
between 1.70 and 2.25 mM (i.e. borderline-high concentration) and one had TG level above 
2.25 mM (i.e. high concentration). The proportion of patients with a positive history of VOC 
or ACS within the previous year was compared between patients with normal TG and those 
with borderline/high TG. Compared to the group with normal TG level, the group with 
borderline/high TG level exhibited a greater proportion of patients with a positive history of 
VOC (33.3 vs 11.9%, p < 0.05) and ACS (25.0 vs 7.1%, p < 0.05), respectively. 
 
Multivariate analysis 
A binary multivariate logistic model was used to identify factors associated with HTN in SCA 
patients and included gender, BMI, TG and blood viscosity. Hb, Hct, hemolytic component or 
RBC counts were not included in the model to avoid co-linearity effects with blood viscosity. 
BMI and TG levels were not significantly correlated. PP was not included in the model 
because it contains some information on the absolute BP level [29,30]. The overall model was 
statistically significant (chi-square = 32.90; df = 4; p < 0.001) and each of the four parameters 
included in the model were significantly associated with HTN: male gender (OR: 3.49; 
95%CI 1.20 to 10.16, p < 0.05), TG (OR: 9.19; 95% CI 2.29 to 36.95, p < 0.01), blood 
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viscosity (OR: 1.35; 95% CI 1.01 to 1.81, p < 0.05) and BMI (OR: 1.37; 95% CI 1.14 to 1.64, 
p < 0.01). Because blood viscosity could only be modestly affected by the hemolytic rate 
[31], a second model was tested and included the previous four covariates plus the hemolytic 
component. This second model was still significant (chi-square = 32.53; df = 5; p < 0.001) 
and retained the same covariates as in the previous model: the hemolytic component was not 
significant. Finally, although the frequency of HU treated patients between the two groups 
were not different, we tested a third binary multivariate logistic model including the four co-
variates of the first model plus the frequency of patients receiving HU treatment since HU 
therapy may modulate hematology and blood rheology. We obtained the same results than 
with the model without HU: i.e., 1) the model was significant (chi-square = 33.679; df = 5; p 
< 0.001) and 2) male gender (OR: 4.20; 95%CI 1.32 to 13.31, p < 0.05), TG (OR: 6.89; 95% 
CI 1.58 to 30.11, p < 0.01), blood viscosity (OR: 1.57; 95% CI 1.02 to 2.73, p < 0.05) and 
BMI (OR: 1.48; 95% CI 1.19 to 1.85, p < 0.01) were still significantly associated with HTN. 
In contrast, HU treatment was not significantly associated with HTN (OR: 1.37; 95% CI 0.35 
to 5.44).  
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Discussion 
The present study demonstrates for the first time that 1) male gender, BMI, TG level and 
blood viscosity are independently associated with relative HTN in SCA; 2) relative HTN is 
not associated with greater VOC or ACS occurrence; 3) borderline/high TG level is 
associated with greater VOC or ACS occurrence.  
 
The impact of atherogenic indices and lipoproteins in arterial wall thickness and stiffness has 
been previously evaluated in children and adolescents not affected by SCA and it has been 
shown that elevated total cholesterol, TG, LDL-C and low HDL-C levels predict subclinical 
atherosclerosis in adulthood [32,33]. However, the lipid profile of SCA population is unique 
in that these patients exhibit lower LDL-C and HDL-C levels than the general population but 
greater TG level and AIP [16]. Although sharing common mechanisms with atherosclerosis, 
SCA vasculopathy clearly differs in that cholesterol accumulation in arterial wall and 
atheromas have not been reported [16].  
 
Recently, associations were reported between increased TG level or AIP and endothelial 
dysfunction in SCA patients [16,18]. These findings suggest that lipids, and more particularly 
TG level, could play a role in the pathophysiology of several SCA-related complications. 
High TG level, associated to low HDL-C level, has been demonstrated to have pro-
atherogenic, pro-thrombotic and pro-oxidant effects in patients with type 2 diabetes or 
metabolic syndrome [34]. However, until now, this pathophysiological aspect of SCA has 
been poorly studied. Our results demonstrated an association between increased TG level and 
relative HTN or HTN. In addition, the proportion of SCA patients having high AIP was two-
fold greater in the HTN group compared to the NORM group. Our findings in SCA adults are 
in agreement with a recent study conducted in obese and non-obese children showing that 
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increased AIP was associated with pre-hypertension in this population [35]. High TG level 
and AIP have been both identified in several cardiovascular and autoimmune inflammatory 
diseases [24,36,37,38]. Although the contribution of TG in the development of cardiac and 
vascular diseases has been challenged [39], several findings suggest that increased TG level 
may cause inflammation [19,40] and oxidative stress in non-SCA population [19], hence 
modulating vascular function. We did not investigate vascular function in the present study. It 
has been shown that carotid-femoral or carotid-radial pulse wave velocity is usually lower in 
SCA patients than in healthy subjects demonstrating that arterial stiffness is reduced in the 
SCA population [41]. Nevertheless, increased PP in the HTN group could reflect greater 
arterial stiffness in this subgroup of SCA patients [30,42] while the positive correlation 
detected between AIP and PP supports a possible role of lipids in arterial stiffening in the 
HTN group.  
 
Because of the low Hct and Hb levels, blood viscosity in SCA patients is usually lower than 
in the general population [10]. However, compared to healthy subjects, the vascular function 
of SCA patients is altered [43] suggesting that further impairment in blood rheology could be 
deleterious for the vascular system [44]. In the present study, blood viscosity was increased in 
the HTN group compared to the NORM group, and remained independently associated with 
HTN in the multivariate regression model. The increased blood viscosity in the HTN group 
was probably the consequence of the lower hemolytic rate, which leads to higher Hb and Hct 
levels. HU treatment and alpha-thalassemia are known to modulate hemolytic rate and the 
level of anemia, but the percentage of patients with alpha-thalassemia or receiving HU was 
not different between the two groups [45,46]. The third binary multivariate logistic model 
confirmed that HU treatment was not a confounding factor in this study. Whatever the reasons 
of the increased Hb and Hct levels in the HTN group, the greater blood viscosity may increase 
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vascular resistance and BP [2]. Recently, we reported a positive association between systemic 
vascular resistance and blood viscosity in children with SCA suggesting that vascular function 
in this disease is unable to cope with an increase of blood viscosity [44]. We also tested 
whether the increased TG level could explain the increased blood viscosity in the HTN group 
but no association between the two parameters was detected (r = -0.15; p = 0.15). Indeed, 
both increased TG levels and blood viscosity could be at the origin of relative HTN in SCA.  
 
As a consequence of the increased resting energy expenditure caused by the increased 
erythropoietic and cardiac activities [47], SCA patients are usually characterized by lower 
BMI values compared to ethnic-matched population. Indeed, in our study, the mean BMI 
value of the two groups was lower (< 25 kg/m2) than the limit defining overweight. 
Nevertheless, we reported an independent association between increased BMI and relative 
HTN, which confirms previous findings in SCA [3,48]. Pegelow et al [3] also demonstrated 
that BP values were higher in male than in females, which is consistent with our findings 
showing an independent association between male gender and HTN in the multivariate model. 
Woods et al [49] previously showed that measurement of BMI only, in SCA, was not 
informative enough to screen for adiposity and obesity. The authors analyzed the body 
composition of SCA patients with normal mean BMI (22.6 kg/m2) and showed a 32.6% fat 
composition, indicating high levels of adiposity. Since fat accumulation and adipocytes 
secretion are responsible for many hormonal changes playing a role in the development of 
vascular dysfunction and HTN in the general population [50,51], we suggest that it could be 
the case in SCA patients too, even if BMI values are normal. Further studies are needed to 
better explore the relationship between BMI, hormonal status and relative HTN in SCA.  
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Rodgers et al [4] previously suggested that relative HTN and acute vaso-occlusive 
manifestations could be associated but the authors did not address this issue. Our results do 
not support this latter hypothesis. However, we observed that SCA patients with 
borderline/high TG level suffered more frequent VOC or ACS events in the previous year 
compared to those with normal TG level. The underlying mechanism is unknown at this time 
but the adverse effects of elevated TG on vascular function and inflammation [16] could 
explain why increased TG level is associated with VOC and ACS. The pathophysiology of 
VOC is extremely complex with several interacting factors such as: blood rheology, 
inflammation, vascular adhesion process, oxidative stress, and now, lipid profile [52]. Further 
studies are clearly warranted to investigate whether the lipid profile could specifically impact 
the macro- and microcirculation of SCA patients and ultimately increase the risks for vaso-
occlusive events.  
 
Our report clearly suggests that male gender, increased TG level, BMI and blood viscosity 
could increase the risk for developing relative HTN or HTN. In addition, for the first time, our 
results support a potential role of moderately elevated TG in the pathophysiology of vaso-
occlusive events, thus providing further evidence of a role of lipids in the SCA 
pathophysiology. Further studies are needed to evaluate the longitudinal associations between 
HTN, lipid profile and the occurrence of acute and chronic complications in SCA patients. In 
addition, nutritional aspects have not been investigated in our study, and vitamin D deficiency 
has been recently reported to participate in the development of hypertension [53]. Further 
studies are needed to address this issue. 
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Table 1: General characteristics of the SCA patients classified according to hypertension 
 NORM HTN 
Sex (M/F) 20/34 23/20 
Age (years) 33.9 ± 13.1 35.4 ± 12.7 
Height (cm) 169 ± 8 171 ± 10 
Weight (kg) 58.7 ± 7.4 66.1 ± 11.1** 
Body mass index (kg/m2) 20.5 ± 2.5 22.7 ± 3.7** 
HbS (%) 84.4 ± 5.8 83.1 ± 5.6 
HbF (%) 7.9 ± 5.8 9.1 ± 6.0 
HU (%) 24.0 14.3 
SpO2 (%) 96.6 ± 2.7 96.6 ± 3.0 
PP (mmHg) 44.3 ± 6.7 49.2 ± 10.2** 
HR (bpm) 76 ± 10 76 ± 12 
Positive history of VOC (%) 13.0 16.3 
Positive history of ACS (%) 9.3 9.3 
Means ± SD. NORM group, patients with blood pressure values below 120/70 mmHg; HTN 
group, patients with BP values > 120/70 mmHg; HU, hydroxyurea; SpO2, oxygen saturation; 
PP, pulse pressure; HR, hear rate; VOC, vaso-occlusive crisis; ACS, acute chest syndrome. 
Significant difference (**p < 0.01). 
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Table 2: Hematological parameters and hemolytic profile in SCA patients according to 
hypertension 
 NORM HTN 
alpha-thalassemia (%) 44.4 41.9 
RBC (1012/L) 2.7 ± 0.5 3.0 ± 0.7** 
WBC (109/L) 9.4 ± 2.4 10.2 ± 2.7 
PLT (109/L) 384.8 ± 118.8 412.2 ± 140.6 
Hb (g/dL) 8.1 ± 1.2 8.8 ± 1.3** 
Hct (%) 22.7 ± 3.3 24.7 ± 3.8** 
MCV (fl) 84.6 ± 9.9 84.3 ± 10.1 
MCHC (pg) 30.3 ± 3.8 30.1 ± 3.8 
RET (%) 217.8 ± 74.8 233.1 ± 73.7 
BIL mM 61.2 ± 39.1 56.2 ± 45.9 
LDH (UI/L) 510.5 ± 148.3 472.1 ± 157.2 
AST (UI/L) 40.7 ± 13.7 36.0 ± 13.0 
Hemolytic component 
(relative unit) 
0.20 ± 0.99 -0.24 ± 0.97* 
Means ± SD. NORM group, patients with blood pressure values below 120/70 mmHg; HTN 
group, patients with BP values > 120/70 mmHg; RBC, red blood cell count; WBC, white 
blood cell count; PLT, platelet count; Hb, hemoglobin; Hct, hematocrit; MCV, mean cell 
volume; MCHC, mean corpuscular hemoglobin concentration; RET, reticulocytes; BIL, 
bilirubin; LDH, lactate dehydrogenase; AST, aspartate aminotransferase. Significant 
difference (*p < 0.05; **p < 0.01). 
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Table 3: Lipid profile and blood viscosity in SCA patients classified according to 
hypertension 
 NORM HTN 
Total cholesterol (mM) 3.1 ± 0.8 3.2 ± 0.7 
HDL-C (mM) 1.0 ± 0.3 0.9 ± 0.1 
LDL-C (mM) 1.7 ± 0.6 1.8 ± 0.5 
TG (mM) 1.0 ± 0.3 1.2 ± 0.6** 
AIP 0.01 ± 0.21 0.10 ± 0.24 
Blood viscosity (mPa/s) 5.8 ± 0.8 6.3 ± 1.3* 
Means ± SD. NORM group, patients with blood pressure values below 120/70 mmHg; HTN 
group, patients with BP values > 120/70 mmHg; HDL-C, high-density lipoprotein-
cholesterol; LDL-C, low-density lipoprotein-cholesterol; TG, triglycerides; AIP, atherogenic 
index of plasma. Significant difference (*p < 0.05; **p < 0.01). 
 
 
	
 
 
